Total Payments
$1,268
2024 Payments
$499.08
Companies
12
Transactions
35
Medicare Patients
796
Medicare Billing
$88,159
Payment Breakdown by Category
Food & Beverage$1,268 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,268 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $329.34 | 5 | $0 (2024) |
| OptiNose US, Inc. | $209.06 | 11 | $0 (2022) |
| Medtronic, Inc. | $148.44 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $135.60 | 3 | $0 (2024) |
| Horizon Therapeutics plc | $121.81 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $118.69 | 7 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $112.63 | 1 | $0 (2024) |
| Intersect ENT, Inc. | $25.73 | 1 | $0 (2022) |
| Aerin Medical Inc. | $21.63 | 1 | $0 (2022) |
| Smith+Nephew, Inc. | $15.90 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $499.08 | 9 | Stryker Corporation ($201.75) |
| 2023 | $309.54 | 7 | Medtronic, Inc. ($148.44) |
| 2022 | $296.25 | 10 | Horizon Therapeutics plc ($121.81) |
| 2021 | $147.93 | 8 | Optinose US, Inc. ($115.51) |
| 2019 | $15.56 | 1 | Stryker Corporation ($15.56) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $95.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/05/2024 | Stryker Corporation | XPRESS LOPROFILE (Device) | Food and Beverage | In-kind items and services | $172.24 | General |
| Category: ENTELLUS | ||||||
| 07/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | Stryker Corporation | SCOPIS ENT (Device) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: INSTRUMENTS | ||||||
| 06/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $112.63 | General |
| Category: Ophthalmology | ||||||
| 06/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2023 | Stryker Corporation | NA (Device), VSP SYSTEM, VSP CRANIAL | Food and Beverage | In-kind items and services | $95.51 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 09/14/2023 | Medtronic, Inc. | NIM VITAL (Device) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Nerve Monitoring Products | ||||||
| 05/25/2023 | Medtronic, Inc. | Sinuva (Drug) | Food and Beverage | In-kind items and services | $125.67 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/19/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: IMMUNOLOGY | ||||||
| 05/19/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Immunology | ||||||
| 03/14/2023 | Olympus America Inc. | — | Food and Beverage | In-kind items and services | $14.01 | General |
| 01/19/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/02/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: TEPEZZA | ||||||
| 11/02/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/14/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/07/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/12/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/07/2022 | Aerin Medical Inc. | — | Food and Beverage | In-kind items and services | $21.63 | General |
| 05/14/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 227 | 243 | $78,498 | $21,082 |
| 2022 | 9 | 305 | 375 | $87,888 | $33,572 |
| 2021 | 8 | 235 | 309 | $73,160 | $30,296 |
| 2020 | 2 | 29 | 29 | $8,077 | $3,209 |
Total Patients
796
Total Services
956
Medicare Billing
$88,159
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $18,379 | $5,432 | 29.6% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 37 | 40 | $20,072 | $5,181 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 52 | $16,824 | $4,585 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 42 | $8,782 | $2,417 | 27.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $7,531 | $1,800 | 23.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $3,656 | $997.15 | 27.3% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 24 | 26 | $3,254 | $670.84 | 20.6% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 43 | 57 | $24,909 | $8,015 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 95 | $14,345 | $6,631 | 46.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 56 | 56 | $12,488 | $4,723 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 43 | $9,546 | $4,195 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $9,802 | $3,993 | 40.7% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 18 | 20 | $4,740 | $1,823 | 38.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $5,620 | $1,801 | 32.1% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 31 | 37 | $3,774 | $1,404 | 37.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 18 | $2,664 | $986.62 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 65 | $14,430 | $6,719 | 46.6% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 23 | 38 | $16,606 | $6,106 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 77 | $11,627 | $5,777 | 49.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $11,492 | $4,346 | 37.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $7,136 | $2,603 | 36.5% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 19 | 21 | $4,977 | $2,258 | 45.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $3,934 | $1,462 | 37.2% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 22 | 28 | $2,958 | $1,025 | 34.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $4,732 | $1,887 | 39.9% |
About Dr. Harry Ching, M.D
Dr. Harry Ching, M.D is a Otolaryngology healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2014. The National Provider Identifier (NPI) number assigned to this provider is 1720405004.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harry Ching, M.D has received a total of $1,268 in payments from pharmaceutical and medical device companies, with $499.08 received in 2024. These payments were reported across 35 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,268).
As a Medicare-enrolled provider, Ching has provided services to 796 Medicare beneficiaries, totaling 956 services with total Medicare billing of $88,159. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Other Specialties Facial Plastic Surgery, Otolaryngology
- Location Las Vegas, NV
- Active Since 03/25/2014
- Last Updated 01/26/2026
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1720405004
Products in Payments
- Xhance (Drug) $209.06
- XPRESS LOPROFILE (Device) $172.24
- DUPIXENT (Biological) $151.12
- Sinuva (Drug) $125.67
- TEPEZZA (Drug) $121.81
- NUCALA (Biological) $118.69
- MIEBO (Drug) $112.63
- NA (Device) $95.51
- SCOPIS ENT (Device) $29.51
- PROPEL (Device) $25.73
- NIM VITAL (Device) $22.77
- LATERA (Device) $16.52
- STRAVIX (Medical Supply) $15.90
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM (Device) $15.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Las Vegas
Mehdi Sina, Md, MD
Otolaryngology — Payments: $118,402
Otolaryngology $118,402
Dr. Oluwafunmilola Okuyemi, M.d, M.D
Otolaryngology — Payments: $46,785
Otolaryngology $46,785
Dr. Robert Wang, M.d., F.a.c.s, M.D., F.A.C.S
Otolaryngology — Payments: $8,928
Otolaryngology $8,928
Suparna Shah, Md, MD
Otolaryngology — Payments: $8,926
Otolaryngology $8,926
Zonia Fiesta, Aprn,Msn, Fnp-Bc, APRN,MSN, FNP-BC
Otolaryngology — Payments: $7,063
Otolaryngology $7,063
Dr. Steven Becker, M.d, M.D
Otolaryngology — Payments: $4,669
Otolaryngology $4,669